TE
Bio-Techne
TECH·NASDAQMinneapolis MNFounded 19763,000 employees
Large CapbiotechPublicOncology
Platform: Reagents Instruments
Market Cap
$12B
All Drugs
5
Clinical Trials
11
Failed / Terminated
5
FDA Approved
1
Stock Price & Catalysts (TECH)
Loading TECH stock data...
Drug Pipeline (5 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Fixatuximab | TEC-8614 | Approved | 4 | CDK2 | Prostate CaALL | ||
| TEC-1111 | TEC-1111 | Phase 1/2 | 1 | B7-H3 | LN | ||
| Doxafotisoran | TEC-4253 | Phase 1 | 2 | GIP-R | SMAMCC | ||
| Sovainavolisib | TEC-8304 | Preclinical | 2 | KRASG12C | Obesity | ||
| Tixasotorasib | TEC-3943 | Preclinical | 2 | PSMA | MigraineLGS |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (12)